Report in English with a Dutch summary (KCE reports 45A)

More documents

Recommendations

Info

178 Screening for Colorectal Cancer: Appendices KCE reports vol.45 4 Guidelines for colonoscopy surveillance after cancer resection: a Consensus Update 69. US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society 2006 Not included Not included 1. Patients with colon and rectal cancer should undergo high quality perioperative clearing. In the case of nonobstructing tumors, this can be done by preoperative colonoscopy. In the case of obstructing colon cancers, computed tomography colonography with intravenous contrast or double contrast barium enema can be used to detect neoplasms in the proximal colon. In these cases, a colonoscopy to clear the colon of synchronous disease should be considered 3 to 6 months after the resection if no unresectable metastases are found during surgery. Alternatively, colonoscopy can be performed intraoperatively. 2. Patients undergoing curative resection for colon or rectal cancer should undergo a colonoscopy 1 year after the resection (or 1 year following the performance of the colonoscopy that was performed to clear the colon of synchronous disease). This colonoscopy at 1 year is in addition to the perioperative colonoscopy for synchronous tumors. 3. If the examination performed at 1 year is normal, then the interval before the next subsequent examination should be 3 years. If that colonoscopy is normal, then the interval before the next subsequent examination should be 5 years. 4. Following the examination at 1 year, the intervals before subsequent examinations may be shortened if there is evidence of hereditary nonpolyposis colorectal cancer or if adenoma findings warrant earlier colonoscopy. 5. Periodic examination of the rectum for the purpose of identifying local recurrence, usually Not included Not included Not included
KCE reports vol.45 Screening for Colorectal Cancer: Appendices 179 Nr. Title Issued by Year Familial Adenomatous Polyposis (FAP) & related 5 Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer 50 Australian Cancer Network Colorectal Cancer Guidelines Revision Committee 2005 FS annually or biennially from age 12 15 years to 30 35 years until polyposis develops. Colonoscopic screening is appropriate for families with attenuated FAP, as recto-sigmoid sparing surgery can be done in this variant of the disease. Once a causative APC mutation has been identified for the family, genetic testing may be used to distinguish mutation-positive and mutation-negative family members. Hereditary Non-Polyposis Colon Cancer (HNPCC) Screening of mutation carriers or individuals affected with HNPCCrelated tumours in Amsterdampositive families should be by full colonoscopy performed annually or at least once every two years, beginning at the age of 25 years or five years earlier than the age of diagnosis of the youngest affected member of the family (whichever is the earliest). Screening first-degree relatives of affected members in Amsterdam positive families where the mutation status is unknown is similar, although colonoscopy can be reduced to two-yearly. More distant relatives can be offered 5yearly colonoscopy. Personal history of CRC resection Intensive follow up for CRC should be considered for patients who have had potentially curable disease, although optimal investigation and pathways are yet to be firmly established. Personal history of colonpolyps All polyps should be at least sampled, and preferably removed. Synchronous polyps should be sought and removed. All patients with colorectal neoplasia completely removed at colonoscopy should then be considered for colonoscopic surveillance according to the following protocols: within 1 y. following incomplete or possible inadequate examination, for example in a subject with multiple adenomas (level II evidence) at 3 y. with large adenomas (>1 cm), adenomas with highgrade dysplasia, villous change in adenomas, three or more adenomas, or aged 60 or more with a first-degre relative with colorectal neoplasia (level II evidence) at 4 to 6 y. in subjects without the risk factors outlined above. (level III-3). Inflammatory bowel disease (IBD) - - Miscellaneous
Page 1 and 2:
Health Technology Assessment Colore
Page 3 and 4:
Health Technology Assessment Colore
Page 5 and 6:
KCE reports vol.45A Colorectale Kan
Page 7 and 8:
Page 9:
Page 12 and 13:
2 Screening for Colorectal Cancer K
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
10 Screening for Colorectal Cancer
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 28 and 29:
Page 30 and 31:
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139: 128 Screening for Colorectal Cancer
Page 238 and 239:
Page 240 and 241:
Page 242 and 243:
Page 244 and 245:
Page 246 and 247:
Page 248 and 249:
Page 250 and 251:
Page 252 and 253:
Page 254 and 255:
Page 256 and 257:
Page 259 and 260:
This page is left intentionally bla
Page 261:
KCE reports 1. Effectiviteit en kos
show all

Report in English with a Dutch summary (KCE reports 45A)

Create successful ePaper yourself

Delete template?

Save as template?